Tarsus Pharmaceuticals, Inc.TARSNASDAQ
Loading
EPS Growth AcceleratingAccelerating
Percentile Rank86
Studio
Year-over-Year Change

Year-over-year earnings per share growth rate

Latest
48.21%
↑ 159% vs avg
Percentile
P86
Within normal range
Streak
3 yr
Consecutive growthAccelerating
Average
-81.98%
Historical baseline
PeriodValue
202548.21%
202433.55%
2023-83.33%
2022-276.12%
202149.24%
2020-450.00%
201922.58%
20180.00%